中国药房2017，Vol.28Issue(14)：1884-1888,5.DOI:10.6039/j.issn.1001-0408.2017.14.04
我院头孢菌素类注射剂皮试费用的经济学分析
Economic Analysis of the Cost of Cephlosporin Injection's Skin Test in Our Hospital
张丽霄 1杨翠翠 1付俊涛 1汪新茹 1张丽珍 1杜书章1
作者信息
- 1. 郑州大学第一附属医院药学部,郑州 450052
- 折叠
摘要
Abstract
OBJECTIVE:To provide reference for standardized management of skin test of cephalosporin injection in our hos-pital. METHODS:In retrospective analysis,skin test of 8 kinds of cephalosporin [cefotaxime(1.0 g),cefotaxime(0.5 g),cefoti-am (1.0 g),cefotiam (0.5 g),ceftazidime (0.5 g),cefminox (0.5 g),cefminox (1.0 g),ceftriaxone (1.0 g)] and the cost of skin test, related cost of allergic reaction induced by cephalosporin injection were analyzed statistically during Sept. 1st, 2015-Aug. 31th,2016. The cost of skin test of cephalosporin injection was compared with allergic reaction cost reduced by skin test. RESULTS:The positive rate of 100330 patients who used above 8 kinds of cephalosporin injections was 6.27%;the rate of skin test was 82.49%;the direct cost of skin test was 3434411.72 yuan;the indirect cost was 141985.12 yuan;the cost of pa-tient was 3162901.44 yuan;the cost of medical insurance was 259096.28 yuan;the cost of the whole society was 3576396.84 yuan. From the perspective of the whole society,the cost of skin test of cephalosporin injections was(447049.61±247395.07)yuan, and allergic reaction cost reduced by skin test was (316075.48 ± 260600.49)yuan. The cost of skin test was significantly higher than allergic reaction cost reduced by skin test,with statistical significance(P<0.05). CONCLUSIONS:Skin test of cephalosporin injection is low in positive rate,has high expense. The government standardizes the management of skin test of cephalosporin injec-tion and reduces the economic burden of patients under the premise of ensuring the safety of drug use.关键词
头孢菌素/注射剂/皮试/药物经济学/过敏反应Key words
Cephalosporin/Injection/Skin test/Pharmacoeconomics/Allergic reaction分类
医药卫生引用本文复制引用
张丽霄,杨翠翠,付俊涛,汪新茹,张丽珍,杜书章..我院头孢菌素类注射剂皮试费用的经济学分析[J].中国药房,2017,28(14):1884-1888,5.
